Ayako Maeda

R&D Center, 7-3-4 Higashi Machi, Ibukidai, Nishi Ku
Kobe, 6512242, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Structural insight into the activation of an Arabidopsis organellar C-to-U RNA editing enzyme by active site complementation.

Structural insight into the activation of an Arabidopsis organellar C-to-U RNA editing enzyme by active site complementation.

Journal: The Plant cell

Published: July 14, 2022

Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.

Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.

Journal: Journal of neurogastroenterology and motility

Published: March 07, 2022

DYW deaminase domain has a distinct preference for neighboring nucleotides of the target RNA editing sites.

DYW deaminase domain has a distinct preference for neighboring nucleotides of the target RNA editing sites.

Journal: The Plant journal : for cell and molecular biology

Published: January 16, 2022

Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats.

Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats.

Journal: Biomedicines

Published: April 21, 2021

Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.

Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.

Journal: Journal of gastroenterology and hepatology

Published: November 27, 2020

Alteration of Colonic Mucosal Permeability during Antibiotic-Induced Dysbiosis.

Alteration of Colonic Mucosal Permeability during Antibiotic-Induced Dysbiosis.

Journal: International journal of molecular sciences

Published: July 29, 2020

Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action.

Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action.

Journal: Bioscience of microbiota, food and health

Published: September 04, 2019

Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.

Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.

Journal: Microbiology and immunology

Published: June 13, 2019

Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis.

Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis.

Journal: Bioscience of microbiota, food and health

Published: August 07, 2018

Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.

Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.

Journal: PloS one

Published: November 30, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026